Static Chart NeuroSense Therapeutics Ltd.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/06/2024 BST			5-day change	1st Jan Change
0.97 ^USD	-4.90%		-11.82%	+23.57%

05-14	NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up	MT
05-07	NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients	CI

Duration

Period